ClearOne, Inc. (CLRO) is a Salt Lake City-based micro-cap that once designed professional audio and video conferencing hardware. After selling its core intellectual property and inventory to Biamp Systems in October 2025, it stopped shipping product and now operates essentially as a transitional shell managing warranty obligations while pursuing a reverse merger with Cortigent, a subsidiary of Vivani Medical (VANI).
Shares changed hands at $5.51 shortly after midday Thursday, a decline of 20.14%, or $1.39, from Wednesday's closing price of $6.90. The direction is unambiguously lower: the stock opened near $6.95 and sold off through the morning. No company announcement, regulatory filing, or analyst revision accompanied the move, leaving market participants to attribute the retreat to the unwinding of the prior session's speculative spike.
No verified news or fundamental catalyst found for Thursday's session. The most recent confirmed disclosures date to the prior week, and none explains a 20% decline: on November 13 the company agreed to issue 999,999 shares at a deemed price of $4.00, retiring $1.24 million of First Finance debt and raising $2.76 million in cash, leaving 3,675,411 shares outstanding. On November 17, ClearOne appeared before a Nasdaq Hearings Panel to appeal the October 8 staff determination to delist for failing the $2.5 million stockholders' equity requirement. Third-quarter results, filed November 10, showed zero revenue from continuing operations and a $709,000 net loss.
The action is instead consistent with a mechanical reversal after an outsized squeeze. Wednesday's advance carried the stock from $4.72 to $6.90, a 46.19% gain that briefly reached $8.65 before sellers emerged, and it came on volume more than double the 20-day average. That intraday fade from the highs signaled exhaustion of the buying impulse rather than fresh accumulation. With short interest at roughly 44% of a float under 900,000 shares, forced covering can lift a thin order book dramatically — and once that demand is satisfied, prices tend to retrace just as quickly. Thursday's decline of roughly 20% recovers only part of Wednesday's gain, a pattern consistent with profit-taking by momentum traders and short sellers rebuilding positions rather than a change in the company's fundamentals.
The stock's recent history supports that reading: over the past 60 sessions it has posted single-day moves of 20% or more eight separate times, including gains of 69.27% on October 23, 65.69% on November 2, and 41.84% on November 16.
Volume has been exceptional. Wednesday's turnover of 28.2 million shares dwarfed the roughly 12.4 million-share 20-day average and represented many times the entire public float, a hallmark of speculative churn in a micro-cap. Thursday's activity was active but lighter, indicating the aggressive buying that dominated the prior session had faded.
The move was company-specific. Communications-equipment peers and broad technology indices showed no comparable swing, and there is no sector or macro narrative that would explain a one-day decline of this magnitude in an $18 million company. Technically, the pullback still leaves the shares above their 50-day moving average near $4.17 and their 200-day average near $4.68, both of which had been reclaimed during the November rally. The $6.90–$8.65 zone established Wednesday now stands as clear overhead resistance, while the $4.70 area marks the first meaningful support shelf.
The score runs from 0 — no meaningful news and a move that is normal for the stock — to 100, which denotes transformative news combined with an extreme, rare price move. ClearOne earns 12 out of 100.
The news component is weak: no verified announcement or filing preceded Thursday's decline, and the only recent items were a small equity and debt settlement and a listing appeal already known to the market. The price component is also modest by this stock's standards. The 20.14% drop was about 1.75 times the stock's average absolute daily move of 11.5% over the last 60 sessions, and moves of that size or larger occurred eight times in that window. Two ordinary components combine into a low score.
The overriding variable is listing status. ClearOne's appeal was heard November 17, and the panel's written decision has not been disclosed; a negative outcome would suspend trading on the Nasdaq Capital Market. The Cortigent merger remains conditional on a public offering of $10–15 million at $4.15 per unit, which at current prices would be raised on dilutive terms, and failure to complete that financing would terminate the transaction. Investors also face a going-concern qualification, just $18,000 in unrestricted cash at quarter-end, a current ratio of 0.48, and related-party debt owed to a controlling shareholder that holds roughly 61% of the stock. With no revenue base and a float under 900,000 shares, expect headline-driven volatility to persist regardless of direction.
Trending AI Robots is Tickeron's curated showcase of automated trading strategies that are performing best under present market conditions. The platform hosts hundreds of AI-driven bots spanning thousands of tickers, and only those with the strongest recent results are surfaced in this section. Bots differ widely by strategy logic, holding period, performance metrics, and the symbols they trade, so the lineup shifts as market conditions evolve. Reviewing the current leaders can help traders see which approaches are working right now — visit the page to explore the live roster.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CLRO declined for three days, in 264 of 311 cases, the price declined further within the following month. The odds of a continued downward trend are 85%.
The 50-day moving average for CLRO moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
CLRO broke above its upper Bollinger Band on November 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CLRO entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CLRO's RSI Indicator exited the oversold zone, 32 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 58 cases where CLRO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on November 18, 2026. You may want to consider a long position or call options on CLRO as a result. In 77 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for CLRO just turned positive on November 18, 2026. Looking at past instances where CLRO's MACD turned positive, the stock continued to rise in 35 of 39 cases over the following month. The odds of a continued upward trend are 90%.
CLRO moved above its 50-day moving average on November 16, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CLRO crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Following a +12.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLRO advanced for three days, in 173 of 212 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLRO's P/B Ratio (-35.181) is very low in comparison to the industry average of (5.210). P/E Ratio (-0.458) is within average values for comparable stocks, (3.688). Projected Growth (PEG Ratio) (0.520) is also within normal values, averaging (0.778). CLRO has a moderately high Dividend Yield (0.399) as compared to the industry average of (0.067). P/S Ratio (0.533) is also within normal values, averaging (11.937).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. CLRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a maker of audio conferencing equipment
Industry TelecommunicationsEquipment